The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 24, 2023 | Healy James | Director, 10% Owner | Disposed to issuer(D) | 20K | — | — |
| Feb 24, 2023 | Healy James | Director, 10% Owner | Tender(U) | 10K | — | — |
| Feb 24, 2023 | de Garidel Marc | Chief Executive Officer, Director | Disposed to issuer(D) | 200K | — | — |
| Feb 24, 2023 | de Garidel Marc | Chief Executive Officer, Director | Tender(U) | 13K | — | — |
| Feb 24, 2023 | de Garidel Marc | Chief Executive Officer, Director | Disposed to issuer(D) | 602K | — | — |
| Feb 24, 2023 | de Garidel Marc | Chief Executive Officer, Director | Disposed to issuer(D) | 726K | — | — |
| Feb 24, 2023 | Thero John F | Director | Disposed to issuer(D) | 59K | — | — |
| Feb 24, 2023 | Thero John F | Director | Disposed to issuer(D) | 36K | — | — |
| Feb 24, 2023 | Pearce Catherine | Chief Operating Officer | Tender(U) | 2K | — | — |
| Feb 24, 2023 | Pearce Catherine | Chief Operating Officer | Tender(U) | 140K | — | — |
| Feb 24, 2023 | Pearce Catherine | Chief Operating Officer | Disposed to issuer(D) | 15K | — | — |
| Feb 24, 2023 | Pearce Catherine | Chief Operating Officer | Disposed to issuer(D) | 110K | — | — |
| Feb 24, 2023 | Pearce Catherine | Chief Operating Officer | Disposed to issuer(D) | 13K | — | — |
| Feb 24, 2023 | Lee June | Director | Disposed to issuer(D) | 48K | — | — |
| Feb 24, 2023 | Kalb Michael Wayne | EVP & Chief Financial Officer | Disposed to issuer(D) | 202K | — | — |
| Feb 24, 2023 | Kalb Michael Wayne | EVP & Chief Financial Officer | Disposed to issuer(D) | 78K | — | — |
| Feb 24, 2023 | Ignelzi Troy A. | Director | Disposed to issuer(D) | 36K | — | — |
| Feb 24, 2023 | Ignelzi Troy A. | Director | Disposed to issuer(D) | 59K | — | — |
| Feb 24, 2023 | Allison David D. | Director | Disposed to issuer(D) | 524 | — | — |
| Feb 24, 2023 | Allison David D. | Director | Disposed to issuer(D) | 881 | — | — |
| Feb 24, 2023 | Allison David D. | Director | Disposed to issuer(D) | 1K | — | — |
| Feb 24, 2023 | Allison David D. | Director | Disposed to issuer(D) | 29K | — | — |
| Feb 24, 2023 | Allison David D. | Director | Disposed to issuer(D) | 1K | — | — |
| Feb 24, 2023 | Freeman Mason | Chief Medical Officer | Tender(U) | 2K | — | — |
| Feb 24, 2023 | Freeman Mason | Chief Medical Officer | Tender(U) | 100 | — | — |
| Feb 24, 2023 | Freeman Mason | Chief Medical Officer | Disposed to issuer(D) | 40K | — | — |
| Feb 24, 2023 | Freeman Mason | Chief Medical Officer | Disposed to issuer(D) | 145K | — | — |
| Feb 24, 2023 | Freeman Mason | Chief Medical Officer | Disposed to issuer(D) | 30K | — | — |
| Feb 24, 2023 | Freeman Mason | Chief Medical Officer | Disposed to issuer(D) | 120K | — | — |
| Feb 24, 2023 | Healy James | Director, 10% Owner | Tender(U) | 6.1M | — | — |
| Feb 24, 2023 | Schwab Andrew J. | 10% Owner | Tender(U) | 487K | — | — |
| Feb 24, 2023 | Schwab Andrew J. | 10% Owner | Tender(U) | 4.0M | — | — |
| Feb 24, 2023 | Schwab Andrew J. | 10% Owner | Tender(U) | 496K | — | — |
| Jan 26, 2023 | Freeman Mason | Chief Medical Officer | Grant(A) | 40K | — | — |
| Jan 26, 2023 | Kalb Michael Wayne | EVP & Chief Financial Officer | Grant(A) | 177K | — | — |
| Jan 26, 2023 | Pearce Catherine | Chief Operating Officer | Grant(A) | 15K | — | — |
| Jan 26, 2023 | de Garidel Marc | Chief Executive Officer, Director | Grant(A) | 200K | — | — |
| Jan 11, 2023 | Pearce Catherine | Chief Operating Officer | Tax withholding(F) | 4K | $28.75 | $115K |
| Jan 11, 2023 | Pearce Catherine | Chief Operating Officer | Option exercise(M) | 13K | — | — |
| Jan 11, 2023 | Pearce Catherine | Chief Operating Officer | Option exercise(M) | 13K | — | $0 |
| Jan 6, 2023 | Allison David D. | Director | Grant(A) | 1K | $8.34 | $13K |
| Nov 28, 2022 | Healy James | Director, 10% Owner | Sell(S) | 6K | $14.32 | $86K |
| Nov 4, 2022 | Kalb Michael Wayne | EVP & Chief Financial Officer | Grant(A) | 25K | — | $0 |
| Nov 4, 2022 | Kalb Michael Wayne | EVP & Chief Financial Officer | Grant(A) | 78K | — | $0 |
| Oct 7, 2022 | Allison David D. | Director | Grant(A) | 524 | $23.85 | $12K |
| Aug 15, 2022 | Sofinnova Partners SAS | 10% Owner | Buy(P) | 133K | $30.00 | $4.0M |
| Aug 15, 2022 | 5AM Partners VI, LLC | 10% Owner | Buy(P) | 487K | $30.00 | $14.6M |
| Aug 15, 2022 | 5AM Partners VI, LLC | 10% Owner | Buy(P) | 113K | $30.00 | $3.4M |
| Aug 11, 2022 | Gap Coinvestments III, LLC | 10% Owner | Buy(P) | 83K | $30.00 | $2.5M |
| Aug 11, 2022 | General Atlantic Genpar (Bermuda), L.P. | 10% Owner | Buy(P) | 83K | $30.00 | $2.5M |
| Aug 11, 2022 | Healy James | Director, 10% Owner | Buy(P) | 500K | $30.00 | $15.0M |
| Aug 11, 2022 | Healy James | Director, 10% Owner | Buy(P) | 6K | $30.00 | $180K |
| Aug 11, 2022 | Sofinnova Management X, L.L.C. | 10% Owner | Buy(P) | 500K | $30.00 | $15.0M |
| Aug 5, 2022 | Healy James | Director, 10% Owner | Option exercise(M) | 29K | $13.60 | $400K |
| Aug 5, 2022 | Healy James | Director, 10% Owner | Option exercise(M) | 29K | — | $0 |
| Jul 8, 2022 | Allison David D. | Director | Grant(A) | 881 | $14.19 | $13K |
| Jun 10, 2022 | Freeman Mason | Chief Medical Officer | Sell(S) | 6 | $15.21 | $91 |
| Apr 8, 2022 | Allison David D. | Director | Grant(A) | 1K | $12.04 | $12K |
| Jan 12, 2022 | Pearce Catherine | Chief Operating Officer | Grant(A) | 26K | — | $0 |
| Jan 11, 2022 | Gap Coinvestments III, LLC | 10% Owner | Buy(P) | 1.7M | $16.00 | $27.2M |
| Jan 11, 2022 | Gap Coinvestments III, LLC | 10% Owner | Conversion(C) | 2.4M | — | — |
| Jan 11, 2022 | Gap Coinvestments III, LLC | 10% Owner | Conversion(C) | 8.3M | — | — |
| Jan 11, 2022 | General Atlantic Genpar (Bermuda), L.P. | 10% Owner | Conversion(C) | 2.4M | — | — |
| Jan 11, 2022 | General Atlantic Genpar (Bermuda), L.P. | 10% Owner | Buy(P) | 1.7M | $16.00 | $27.2M |
| Jan 11, 2022 | General Atlantic Genpar (Bermuda), L.P. | 10% Owner | Conversion(C) | 8.3M | — | — |
| Jan 11, 2022 | Coelho Mary Theresa | EVP CFO & Chief BD Officer | Buy(P) | 100 | $16.00 | $2K |
| Jan 11, 2022 | de Garidel Marc | Chief Executive Officer, Director | Buy(P) | 13K | $16.00 | $200K |
| Jan 11, 2022 | Freeman Mason | EVP Clinical Development | Buy(P) | 100 | $16.00 | $2K |
| Jan 11, 2022 | Freeman Mason | EVP Clinical Development | Buy(P) | 3K | $16.00 | $40K |
| Jan 11, 2022 | Pearce Catherine | Chief Operating Officer | Buy(P) | 2K | $16.00 | $24K |
| Jan 11, 2022 | Pearce Catherine | Chief Operating Officer | Buy(P) | 750 | $16.00 | $12K |
| Jan 11, 2022 | Healy James | Director, 10% Owner | Buy(P) | 325K | $16.00 | $5.2M |
| Jan 11, 2022 | Healy James | Director, 10% Owner | Conversion(C) | 5.2M | — | — |
| Jan 11, 2022 | Healy James | Director, 10% Owner | Conversion(C) | 13.6M | — | $0 |
| Jan 11, 2022 | Healy James | Director, 10% Owner | Conversion(C) | 4.3M | — | $0 |
| Jan 11, 2022 | Sofinnova Capital IX | 10% Owner | Conversion(C) | 3.9M | — | — |
| Jan 11, 2022 | Sofinnova Capital IX | 10% Owner | Buy(P) | 220K | $16.00 | $3.5M |
| Jan 11, 2022 | Sofinnova Capital IX | 10% Owner | Conversion(C) | 3.1M | — | $0 |
| Jan 11, 2022 | Sofinnova Capital IX | 10% Owner | Conversion(C) | 10.0M | — | $0 |
| Jan 11, 2022 | Sofinnova Venture Partners X, L.P. | 10% Owner | Buy(P) | 325K | $16.00 | $5.2M |
| Jan 11, 2022 | Sofinnova Venture Partners X, L.P. | 10% Owner | Conversion(C) | 5.2M | — | — |
| Jan 11, 2022 | Sofinnova Venture Partners X, L.P. | 10% Owner | Conversion(C) | 4.3M | — | $0 |
| Jan 11, 2022 | Sofinnova Venture Partners X, L.P. | 10% Owner | Conversion(C) | 13.6M | — | $0 |
| Jan 11, 2022 | CinRx Pharma, LLC | 10% Owner | Conversion(C) | 1.2M | — | — |
| Jan 11, 2022 | CinRx Pharma, LLC | 10% Owner | Conversion(C) | 2.0M | — | $0 |
| Jan 11, 2022 | CinRx Pharma, LLC | 10% Owner | Conversion(C) | 2.1M | — | $0 |
| Jan 11, 2022 | Parmar Kush | 10% Owner | Conversion(C) | 3.7M | — | — |
| Jan 11, 2022 | Parmar Kush | 10% Owner | Conversion(C) | 184K | — | — |
| Jan 11, 2022 | Parmar Kush | 10% Owner | Buy(P) | 158K | $16.00 | $2.5M |
| Jan 11, 2022 | Parmar Kush | 10% Owner | Buy(P) | 313K | $16.00 | $5.0M |
| Jan 11, 2022 | Parmar Kush | 10% Owner | Conversion(C) | 10.0M | — | $0 |
| Jan 11, 2022 | Parmar Kush | 10% Owner | Conversion(C) | 2.5M | — | $0 |
| Jan 11, 2022 | Parmar Kush | 10% Owner | Conversion(C) | 625K | — | $0 |
| Jan 6, 2022 | Lee June | Director | Grant(A) | 48K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).